INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

This adverse event was reported 4395 times

These drugs are most commonly taken by patients reporting INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS:

# Drug Count
0 DORNASE ALFA 1953
1 LUMACAFTOR AND IVACAFTOR 1395
2 TOBRAMYCIN 1364
3 TEZACAFTOR AND IVACAFTOR 1157
4 PANCRELIPASE 1101
5 ALBUTEROL SULFATE 942
6 AZTREONAM 765
7 SODIUM CHLORIDE 587
8 SODIUM CHLORIDE OPHTHALMIC OINTMENT 587
9 ERGOCALCIFEROL 555
See all common drugs associated with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS

INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Penem Antibacterial [EPC] 1 0.5000
1 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1888 0.1533
2 Recombinant Human Deoxyribonuclease 1 [EPC] 1953 0.1374
3 Polymyxin-class Antibacterial [EPC] 48 0.0735
4 Aminoglycoside Antibacterial [EPC] 1415 0.0535
5 Vitamin K [EPC] 212 0.0404
6 Monobactam Antibacterial [EPC] 45 0.0277
7 Folate Analog [EPC] 1 0.0270
8 Bile Acid [EPC] 214 0.0193
9 Antihypoglycemic Agent [EPC] 33 0.0166
See all drug classes enriched for association with INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS